1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. COHERUS BIOSCIENCES INC
Coherus Biosciences Inc
XNAS: CHRS

Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

Read More
1.75 -0.01 (-0.57%)
33.21% Fall from 52W High
906.3K
XNAS Volume

XNAS 24 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Mid Valuation
47.7 / 100
Momentum Score
Technically Neutral
58.4 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
7
1Yr Price target upside is 286%
4 analysts

11

S

10

W

4

O

0

T

SWOT Analysis

Coherus Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..